SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Phibro Animal Health Corp – ‘NT 10-Q’ for 12/31/04

On:  Tuesday, 2/15/05, at 9:45am ET   ·   Effective:  2/15/05   ·   For:  12/31/04   ·   Accession #:  950123-5-1854   ·   File #:  333-64641

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 2/15/05  Phibro Animal Health Corp         NT 10-Q    12/31/04    1:6K                                     RR Donnelley/FA

Notice of a Late Filing of a Form 10-Q   —   Form 12b-25
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: NT 10-Q     Nt 1O-Q                                                2     11K 

NT 10-Q1st Page of 2TOCTopPreviousNextBottomJust 1st
 

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12B-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 333-64641 CUSIP NUMBER 71820 AC 3 (Check One): /_/ Form 10-K /_/ Form 20-F /_/ Form 11-K /X/ Form 10-Q /_/ Form N-SAR For Period Ended: December 31, 2004 /_/ Transition Report on Form 10-K /_/ Transition Report on Form 20-F /_/ Transition Report on Form 11-K /_/ Transition Report on Form 10-Q /_/ Transition Report on Form N-SAR For the Transition Period Ended: ____________ NOTHING IN THIS FORM SHALL BE CONSTRUED TO IMPLY THAT THE COMMISSION HAS VERIFIED ANY INFORMATION CONTAINED HEREIN. If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: _____________________ PART I - REGISTRANT INFORMATION Phibro Animal Health Corporation -------------------------------------------------------------------------------- Full Name of Registrant N/A -------------------------------------------------------------------------------- Former Name if Applicable 65 Challenger Road -------------------------------------------------------------------------------- Address of Principal Executive Office (Street and Number) Ridgefield Park, New Jersey 07660 -------------------------------------------------------------------------------- City, State and Zip Code PART II - RULES 12B-25(B) AND (C) If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate) /X/ (a) The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense; (b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, 11-K or Form N-SAR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q, or portion thereof will be filed on or before the fifth calendar day following the prescribed due date; and (c) The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.
NT 10-QLast Page of 2TOC1stPreviousNextBottomJust 2nd
PART III - NARRATIVE State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, N-SAR, or the transition report or portion thereof, could not be filed within the prescribed time period. The Registrant requires additional time to determine the accounting treatment for the sale of its Rixensart, Belgium plant and related assets under a Purchase Agreement dated December 16, 2004. PART IV - OTHER INFORMATION (1) Name and telephone number of person to contact in regard to this notification Richard G. Johnson (201) 329-7300 ------------------ ------------------ ------------------ (Name) (Area Code) (Telephone Number) (2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s). /X/ Yes /_/ No -------------------------------------------------------------------------------- (3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? /_/ Yes /X/ No If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made. -------------------------------------------------------------------------------- Phibro Animal Health Corporation. -------------------------------------------- (Name of Registrant as Specified in Charter) has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized. Date: February 14, 2005 By: /s/ Richard G. Johnson --------------------------- Richard G. Johnson Chief Financial Officer

Dates Referenced Herein   and   Documents Incorporated by Reference

Referenced-On Page
This ‘NT 10-Q’ Filing    Date First  Last      Other Filings
Filed on / Effective on:2/15/058-K
2/14/052
For Period End:12/31/04110-Q,  10-Q/A
12/16/042
 List all Filings 
Top
Filing Submission 0000950123-05-001854   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Wed., May 1, 9:59:45.1pm ET